Axim International News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.05.18	Tori Spelling Hosts New Reality TV Series On Beauty And Fashion Backed By Industry (PR Newswire)
28.02.18	Medical Marijuana, Inc. Major Investment AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules (PR Newswire)
11.12.17	Alternate Health's Investor Webcast And Presentation Now Available For On-Demand Viewing At VirtualInvestorConferences.com (PR Newswire)
11.12.17	Alternate Health's Investor Webcast And Presentation Now Available For On-Demand Viewing At VirtualInvestorConferences.com (PR Newswire)
21.11.17	Medical Marijuana, Inc. Reports Third Quarter 2017 Financial Results and Operational Highlights: Shows Record 255% Gross Profit Increase (PR Newswire)
15.11.17	Holt Renfrew Ogilvy redéfinira l'expérience du luxe à Montréal (PR Newswire)
03.10.17	Rockwell announces voting results of the annual general and special meeting of shareholders (PR Newswire)
27.09.17	Enforcer Gold Drills 782 g/t Au on the No. 2 Vein at the Montalembert Gold Project (PR Newswire)
25.09.17	Le gouvernement du Canada investit dans la sécurité à l'aéroport de Peace River (PR Newswire)
19.09.17	Global Legal Cannabis Sales Projected to Grow (PR Newswire)
13.09.17	Biosynthesis Technology Could Transform Cannabinoid Production (PR Newswire)
13.09.17	Biosynthesis Technology Could Transform Cannabinoid Production (PR Newswire)
07.09.17	Legal and Medical Cannabis Market Investments on the Rise (PR Newswire)
03.08.17	Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related... (PR Newswire)
27.07.17	Medical Marijuana, Inc Major Investment AXIM Biotech Enters Agreement With Israel-Based CRO To Begin Clinical POC Study For Treatment Of Restless Leg Syndrome (PR Newswire)
27.07.17	Biotech Players Lead the Growth Charge in the Legal Cannabis Market (PR Newswire)
27.07.17	Biotech Players Lead the Growth Charge in the Legal Cannabis Market (PR Newswire)
27.06.17	Reuters Features Medical Marijuana, Inc.'s Major Investment Company AXIM Biotech In Article Citing Company's Development Of Marijuana-Based Painkiller To Combat Opioid Crisis (PR Newswire)
27.06.17	CBD Based Products Fueling Cannabis Industry Revival (PR Newswire)
27.06.17	CBD Based Products Fueling Cannabis Industry Revival (PR Newswire)
26.06.17	Medical Marijuana, Inc. Major Investment AXIM Biotech Files Patent On Controlled Release Chewing Gum To Provide Opioid Addiction Treatment (PR Newswire)
22.06.17	Market Data Shows Growth in the Cannabis Industry (PR Newswire)
06.06.17	Legal Cannabis and CBD Markets are Projected to Grow (PR Newswire)
24.05.17	CBD Market Becomes Major Part of the Cannabis Industry (PR Newswire)
17.05.17	SeeThruEquity Initiates Coverage On Medical Marijuana, Inc. Investment Company AXIM Biotech (OTC: AXIM) With A Target Price Of $17.00 (PR Newswire)
17.05.17	Cannabis-based Therapies With Potential to Dull the Pain of Opioid Abuse (PR Newswire)
17.05.17	Cannabis-based Therapies With Potential to Dull the Pain of Opioid Abuse (PR Newswire)
16.05.17	Legal Cannabis Products are Gaining Popularity (PR Newswire)
04.05.17	Medical Marijuana, Inc. présente ses résultats opérationnels et financiers pour 2016 : les ventes de produits ont augmenté de 66 % entre le 1er et le 4e trimestres (PR Newswire)
03.05.17	Medical Marijuana, Inc. Major Investment AXIM Biotech Moves Forward With Development Of MedChew Rx Pharmaceutical Chewing Gum (PR Newswire)
03.05.17	Medical Marijuana, Inc., veröffentlicht Finanzergebnisse für das Geschäftsjahr 2016 und Eckdaten für das operative Geschäft -- Produktabsatz im Quartalsvergleich steigt um 66 % (1.-4. Quartal) (PR Newswire)
02.05.17	Medical Marijuana, Inc. Reports Year End 2016 Financial Results and Operational Highlights - Product Sales by Quarter Increased 66% Q1-Q4 (PR Newswire)
02.05.17	Medical Marijuana, Inc. Reports Year End 2016 Financial Results and Operational Highlights - Product Sales by Quarter Increased 66% Q1-Q4 (PR Newswire)
02.05.17	The Growth of the Hemp CBD Markets (PR Newswire)
24.04.17	Growth in the Cannabis Market Sector for Medical and Recreational Purposes (PR Newswire)
19.04.17	Developments in the Legal Cannabis Market (PR Newswire)
17.04.17	Big Investors Backing a Marijuana Boom in 2017 (PR Newswire)
12.04.17	The Legal Cannabis Market Expected to Witness Wider Adoption (PR Newswire)
05.04.17	Marijuana Market Offers Variety of Investment Options and Consistent, Long-Lasting Growth Potential (PR Newswire)
30.03.17	Legal Cannabis Market is Rapidly Developing (PR Newswire)
29.03.17	Le principal investissement de Medical Marijuana, Inc. AXIM Biotech signe un accord sur les conditions et modalités avec la société d'API américaine pour développer un produit bioéquivalent au Marinol (PR Newswire)
28.03.17	AXIM Biotech, ein Investmentunternehmen von Medical Marijuana, Inc., unterzeichnet Term Sheet Agreement mit US-amerikanischem API-Hersteller, um einen Bio-Ersatz für Marinol zu entwickeln (PR Newswire)
28.03.17	Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Term Sheet Agreement With U.S. API Company To Develop Bioequivalent Product To Marinol (PR Newswire)
28.03.17	Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Term Sheet Agreement With U.S. API Company To Develop Bioequivalent Product To Marinol (PR Newswire)
28.03.17	The Growth of Legal Cannabis in Approved States (PR Newswire)
21.03.17	Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Axim International Inc

Aktien Top/Flop

Meistgelesene Nachrichten